Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
  •  
Login | Create an Account

27th Psychiatric Pharmacotherapy Update • CME, CNE, APA, Social Work


2015 Psychiatric Pharmacotherapy Update • October 22-23 • Austin

The University of Texas College of Pharmacy welcomes you to the 2015 Psychiatric Pharmacotherapy Update CE event, in Austin, Texas on October 23-24. The Psychiatric Pharmacotherapy Update traditionally provides 15 hours of CEU's on current treads in mental illness treatment for pharmacists, physicians, psychiatrists, psychologists, advance practice nurses, counselors, and social workers.

Date: Oct 22, 2015 07:00 AM - Oct 23, 2015 06:00 AM

Fee

$425.00

CE Hours

15.00

CE Units

1.500

Registration closes on Oct 24, 2015 12:00 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Counselors
  • Nurses
  • Physician Assistant
  • Physicians
  • Psychiatrists
  • Psychologists
  • Social Workers

Requirements for CE Credit

Continuing Medical Education:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Texas Medical Association (TMA) through the joint providership of the Texas Department of State Health Services and The University of Texas at Austin College of Pharmacy. The Texas Department of State Health Services is accredited by TMA to provide continuing medical education for physicians.

Continuing Medical Education:
The Texas Department of State Health Services is accredited by the Texas Medical Association to provide continuing medical education for physicians. The Texas Department of State Health Services, Continuing Education Service (TMA provider #4006803) designates this live activity for a maximum of 15 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This event has been approved by the Texas Department of State Health Services, Continuing Education Service for 4 credits in medical ethics and/or professional responsibility.

CNE

 

Continuing Nursing Education: 
The Texas Department of State Health Services, Continuing Education Service is an accredited provider (P0180) of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.  The Texas Department of State Health Services, Continuing Education Service has awarded 15 contact hour(s) of Continuing Nursing Education.

 

 

Social Work CEUs 
The Texas Department of State Health Services, Continuing Education Service under sponsor number (CS3065) expiration date of December 31, 2015, has been approved by the Texas State Board of Social Worker Examiners (1-800-232-3162) to offer continuing education contact hours to social workers.  The Texas Department of State Health Services, Continuing Education Service has awarded 15 contact hours of Continuing Social Work Education.
apalogo American Society for the Advancement of Pharmacotherapy (ASAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. ASAP maintains responsibility for this program and its content. This conference is accredited for 15 hours of CEU.
 

Please choose a Fee Type from the Drop Down Menu Below:
I am a
 

 

Registration closes on Oct 24, 2015 at 12:00 AM

Registration Closed  

Date: 10/22/15
Time: 07:45 AM - 08:00 AM
Registration Closed  

Registration Closed  

Objectives

  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses,m and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
  • Review pharmacology, adverse effects., drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years.

Activity Number

0067-0000-15-100-L04-P
Date: 10/22/15
Time: 08:00 AM - 09:15 AM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Define treatment resistant depression
  • Discuss trends in managing treatment resistant depression today
  • Critically review patient case studies on current approaches to patients with treatment resistant depression.

Activity Number

0067-0000-15-101-L01-P
Date: 10/22/15
Time: 09:00 AM - 10:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe empirically based treatments, including both psychotherapy and pharmacotherapy, for pediatric patients with depression.
  • Discuss consensus guidelines for medication treatment algorithms for childhood and adolescence depressive disorders. (Case studies)

Activity Number

0067-0000-15-102-L01-P
Date: 10/22/15
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the impact of nutrition, exercise, sleep, hormones, substances, and lifestyle on behavior and learning.
  • Assess the risks of imbalances in biological factors related to health/wellness, behavior, and learning.
  • Recognize first-line non-drug approaches and how to improve outcomes in treatment.

Activity Number

0067-0000-15-103-L04-P
Date: 10/22/15
Time: 11:30 AM - 12:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe tips for diagnosing and treating patients with intellectual disabilities and comorbid mental illness
  • Describe empirically based treatments, including both psychotherapy and pharmacotherapy –case studies

Activity Number

0067-0000-15-104-L01-P
Date: 10/22/15
Time: 01:15 PM - 02:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Identify best practices and trends for use of long acting injectable in outpatient and clinical settings.
  • Discuss clinical and ethical dilemmas resulting from the use of long- acting injections.
  • Critically discuss the evidence-based management of long- acting injectables

Activity Number

0067-0000-15-105-L01-P
Date: 10/22/15
Time: 02:15 PM - 03:30 PM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Compare and contrast use of the new FDA pregnancy and lactation labeling with the use of previously utilized systems.
  • Formulate plans for assessment and treatment of the pregnant or breastfeeding psychiatric parent.
  • Utilize psychiatric pharmacotherapy toolkit of best practices when treating pregnant and breastfeeding patients.
  • Recognize ethical dilemmas related to use of psychotropic agents during pregnancy lactation.

Activity Number

0067-0000-15-106-L01-P
Date: 10/22/15
Time: 03:45 PM - 05:00 PM

CE Hours

1.25
Registration Closed  

Registration closes on Oct 24, 2015 at 12:00 AM

Registration Closed  

Activity Number

0067-0000-15-107-L01-P
Date: 10/23/15
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Activity Number

0067-0000-15-108-L01-P
Date: 10/23/15
Time: 09:00 AM - 10:00 AM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Define basic understanding of genetic principles applicable to the study of pharmacogenomics
  • Discuss outcomes of pharmacogenomics studies related to psychotropic agents
  • Explain applicability of pharmacogenomics to the psychiatric patient receiving psychotropic agents

Activity Number

0067-0000-15-109-L04-P
Date: 10/23/15
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Evidence for using psychotropic medications in the elderly
  • Cognitive effects of psychotropics in the elderly
  • Management of cognitive effects of psychotropic medications in the elderly

Activity Number

0067-0000-15-110-L01-P
Date: 10/23/15
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss consequences of alcohol use before and during pregnancy
  • Explain the scope and problems of FASD's and the psychiatric effects of prenatal alcohol use on the developing fetus.
  • Discuss ethical dilemmas for practitioners in treatment of mother and child regarding fetal alcohol disorders.

Activity Number

0067-0000-15-111-L01-P
Date: 10/23/15
Time: 12:30 PM - 01:45 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the pathophysiology and the challenges associated with diagnosis of epileptic seizures.
  • Identify new treatment options available for management of epilepsy and apply them to patient cases using evidence-based medicine.
  • Compare newer antiepileptic drugs with older agents and discuss their role in treating epilepsy
  • Explain management of epilepsy in special populations such as pregnant females, mental retardation and TBI patients

Activity Number

0067-0000-15-112-L01-P
Date: 10/23/15
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Evaluate diagnostic methods and treatment of ADHD in adults.
  • Identify the differences between stimulant and non-stimulant treatments
  • Identify the differential diagnosis of attention problems in adulthood.
  • Discuss how to use both pharmacological and psychosocial interventions in adult ADHD
  • Discuss misuse of diversion of stimulants when treating adults with ADHD.

Activity Number

0067-0000-15-113-L01-P
Date: 10/23/15
Time: 03:00 PM - 04:00 PM

CE Hours

1.00
Registration Closed  



System Requirements
Please ensure the computer system you plan to use meets the following minimum requirements:
  • Operating System: Windows 7 or higher, macOS Sierra (10.12) or higher
  • Internet Browser: Chrome 30 or higher, Firefox 27 or higher, Internet Explorer 11, Microsoft Edge, Safari 9 or higher
  • Internet connection: Cable, High-speed DSL, and any other medium that is internet accessible
  • Peripherals: Computer speakers or headphones Media Viewing Requirements: Adobe Reader, HTML5
Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice.Activities produced by UT Continuing Pharmacy Education are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Texas at Austin College of Pharmacy.
 
The University of Texas at Austin College of Pharmacy • Continuing Pharmacy Education
2409 University Ave., Stop A1904 | Austin, Texas 78712
Comments to:  UTpharmacyCE@austin.utexas.edu
College of Pharmacy, The University of Texas at Austin
 
LMS Powered By: Learning ExpressCE
Copyright © 2024 University of Texas at Austin College of Pharmacy. All Rights Reserved.
About Us Privacy Policy Terms of Service